WautersMElseviersJVaesBet al. Mortality, hospitalisation, institutionalisation in community-dwelling oldest old: the impact of medication. Arch Gerontol Geriatrics2016;65:9-16.
2.
JyukkäJEnlundJKorhonenMJet al. Polypharmacy status as an indicator of mortality in an elderly population. Drugs Aging2009;26(12):1039-48.
3.
KaurSMitchellGVitettaLRobertsMS.Interventions that can reduce inappropriate prescribing in the elderly. Drugs Aging2009;26(12):1013-28.
4.
TrenamanSBowlesSKMalleryLet al. Innovative collaborative practice to optimize pharmacotherapy for frail older patients. Can J Hosp Pharm2014;67(5):373-8.
5.
FlanaganPViraniABakerWRoelantsH.Pharmacists making house calls: innovative role or overkill?Can J Hosp Pharm2010;63(6):412-19.
6.
PammettRJorgensenD.Eligibility requirements for community pharmacy medication review services in Canada. Can Pharm J (Ott)2014;147:20-4.
7.
ScottIHilmerSNReeveEet al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med2015;175(5):827-34.
8.
Rodríguez-MañasLFéartCMannGet al. Searching for an operational definition of frailty: a Delphi method based consensus statement: the frailty operative definition-consensus conference project. J Geront A Biol Sci Med Sci2013;68(1):62-7.
9.
CleggAYoungJIliffeSet al. Frailty in elderly people. Lancet2013;381:752-62.
10.
FriedLPFerrucciLDarerJet al. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol Med Sci2004;59(3):255-63.
11.
OwensNJSillimanRAFretwellMD.The relationship between comprehensive functional assessment and optimal pharmacotherapy in the older patient. Ann Pharmacother1989;23:847-54.
12.
OwensNJFretwellMDWilleyCMurphySS.Distinguishing between the fit and frail elderly, and optimising pharmacotherapy. Drugs Aging1994;4(1):47-55.
13.
CullinanSO’MahonyDO’SullivanDByrneS.Use of a frailty index to identify potentially inappropriate prescribing and adverse drug reaction risks in older patients. Age Ageing 2016;45:115-20.
14.
GillTMGahbauerEAAlloreHGHanL.Transitions between frailty states among community-living older persons. Arch Intern Med2006;166:418-23.
15.
Rodríguez-MañasLFriedLP.Frailty in the clinical scenario. Lancet2014;385(9968):e7-e9.
16.
TrevisanCVeroneseNMaggiSet al. Factors influencing transitions between frailty states in elderly adults: the Progetto Veneto Anziani longitudinal study. J Am Geriatr Soc2017;65(1):179-84.
17.
RothmanMDLeo-SummersLGillTM.Prognostic significance of potential frailty criteria. J Am Geriatr Soc2008;56(12):2211-6.
18.
WoolcottJCRichardsonKJWiensMOet al. Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med2009;169(21):1952-60.
19.
InouyeSK.Delirium in older persons. N Engl J Med2006;354(11):1157-65.
20.
GarfinkelDZur-GilSBen-IsraelJ.The war against polypharmacy: a new cost-effective geriatric-palliative approach for improving drug therapy in disabled elderly people. Isr Med Assoc J2007;9:430-4.
21.
GarfinkelDManginD.Feasibility study of a systematic approach for discontinuation of multiple medications in older adults. Arch Intern Med2010;170(18):1648-54.
22.
HardyJEHilmerS.Deprescribing in the last year of life. J Pharm Pract Res2011;41(2):146-51.
23.
RockwoodKSongXMacKnightCet al. A global clinical measure of fitness and frailty in elderly people. CMAJ2005;173(5):489-94.
SchoonYBongersKVan KempenJet al. Gait speed as a test for monitoring frailty in community-dwelling older people has the highest diagnostic value compared to step length and chair rise time. Eur J Phys Rehabil Med2014;50: 693-701.
26.
OddenMCPeraltaCAHaanMNCovinskyKE.Rethinking the association of high blood pressure with mortality in elderly adults. Arch Intern Med2012;172(15): 1162-8.
27.
MoroniMZocchiDBolognesiDet al. The ‘surprise’ question in advanced cancer patients: a prospective study among general practitioners. Palliat Med2014;28(7): 959-64.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.